Skip to Main Content

Paper Details

Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancer.
Invest New Drugs
14
2019
Author NameAffiliation
Sunil SharmaDivision Clinical Sciences, Translational Genomics Research Institute (TGen)
  • 1 - 1

Datasets

Release 1.2